Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

Journal of Infectious Diseases

Volumn 176, Issue 6, 1997, Pages 1428-1436

  Karron, R A ^a   Wright, P F ^a   Crowe J E , Jr ^a   Clements Mann, M L ^a   Thompson, J ^a   Makhene, M ^a   Casey, R ^a   Murphy, B R ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CHILD; CHIMPANZEE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOGENICITY; INFANT; INTRANASAL DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TEMPERATURE SENSITIVITY; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0030657620     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514138     Document Type: Article

References (39)